Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
the NGF-Call AiNed ELSA Labs). The ELSA4TI Lab is led by Prof Ming Cao, Director of the Jantina Tammes School of Digital Society, Technology and AI. ELSA4TI focuses on the ethical, legal, social and
-
/research-groups/CRITIX/ ) headed by Prof. Marcus Völp. The team focuses on critical information infrastructures and cyber-physical systems with the aim to protect our most sensitive and valuable assets. We
-
a highly motivated candidate with: A first-class or upper second-class degree (or equivalent) in Materials Science, Chemistry, Physics, Chemical Engineering, or a related discipline. Experience in
-
Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg | Magdeburg, Sachsen Anhalt | Germany | 2 days ago
The Department of Process Systems Engineering (Director: Prof. Dr.-Ing. Kai Sundmacher) at the Max Planck Institute for Dynamics of Complex Technical Systems is inviting applications for the PhD
-
• Scientific publishing Your qualifications: • Completed academic university degree (university diploma / M.Sc.) in Computer Science, Geoscience, Physics, Data Science, or comparable subjects • Experience in
-
profound knowledge in computational and theoretical physics/chemistry. Capability of team work is essential. Skills in high-performance computing, materials chemistry, theoretical chemistry, molecular
-
fields (e. g. physics, computer science, electrical/electronic engineering, chemistry etc.). The knowledge of Python, C or other programming languages in use for accelerator facilities is advantageous. We
-
, which will consist of the PhD researcher, a PostDoc researcher (R programmer, consultant), undergraduate students, and Prof. Jakub Hofman. 4-year Ph.D. programme with financial support for 4 years
-
discipline relevant to our research fields (e. g. physics, computer science, electrical/electronic engineering, chemistry etc.). The knowledge of Python, C or other programming languages in use for accelerator
-
The vacancy is within the group of Associate Prof. Dr. Anna Salvati at the Department of Nanomedicine Drug Targeting of the Groningen Research Institute of Pharmacy (GRIP), Faculty of Science and